{
    "item_type": "proposal",
    "title": "Endothelial immunosuppressive mystery genes for alternative immunotherapy: artificial intelligence-driven target discovery and lipid nanoparticle/RNA-based target validation",
    "descriptions": [
        "Abstract:\n\nTitle: Endothelial immunosuppressive mystery genes for alternative immunotherapy: artificial intelligence-driven target discovery and lipid nanoparticle/RNA-based target validation\n\nThe proposed project aims to revolutionize the field of alternative immunotherapy by identifying and validating new targets within the immunomodulatory gene signatures of endothelial cells. Although 30% of the human coding genome remains poorly annotated, this initiative focuses specifically on the endothelial cell subtype, known for its immunosuppressive properties within the tumor microenvironment. To address this challenge, we introduce two innovative tools: SCMYSTERYDENTIFIER, an AI-based platform designed to predict immunosuppressive functions for uncharacterized endothelial genes, and REVOLT, a technology enabling rapid, cost-effective generation of endothelial cell-specific knockout mice through EC-selective lipid nanoparticles carrying sgRNA.\n\nOur ambitious objectives include the validation of 50 targets and the identification and patenting of 5 novel targets, which are critical for endothelial cell-mediated immunosuppression. With an estimated cost of 300€ per knockout mouse model, our approach not only promises to improve the efficacy of anti-cancer immunotherapies and overcome resistance but also sets a new precedent in terms of speed and affordability.\n\nThe project stands out from previous grants in its unique focus, ambitious scope, and profound societal impact. It is poised to deliver significant knowledge gains in the field of immunotherapy and provide the research community, including academia and pharma, with powerful tools to accelerate the pace of genetic research in vascular biology. The overarching vision is to demystify the mystery genome, unlocking formidable opportunities for both knowledge enhancement and therapeutic advancements."
    ],
    "origin": "LLM",
    "llm_engine": "gpt-4-1106-preview",
    "generation_prompt_uid": "a0959e832e8584be425e98c3246364ad",
    "generation_prompt_nickname": "from_json_details",
    "generation_prompt_text": "Write an abstract for a grant proposal based on the following details provided in JSON format. The JSON includes the title and key characteristics of the proposed project.\n\nPlease limit the response to 255 words or less.\n\n---\n\n**Description:**\n\n{'proposal_name': 'Endothelial immunosuppressive mystery genes for alternative immunotherapy: artificial intelligence-driven target discovery and lipid nanoparticle/RNA-based target validation', 'proposal_details': {'previous_grants_comparison': {'topic_difference': True, 'ambition_difference': True, 'societal_impact_focus': True}, 'research_focus': {'cell_subtype': 'endothelial cell', 'cell_subtype_nickname': 'IMECs', 'relevance': 'alternative immunotherapy development'}, 'therapeutic_potential': {'gene_silencing_impact': 'improves efficacy and overcomes resistance', 'affected_area': 'immunosuppressive tumor endothelium'}, 'target_discovery': {'unknown_targets': 'mystery genes', 'functional_annotation_lacking_percentage': 30, 'human_coding_genome_percentage': 30}, 'tools_developed': {'AI_tool_name': 'SCMYSTERYDENTIFIER', 'AI_tool_purpose': 'predict new immunosuppressive functions', 'validation_technology_name': 'REVOLT', 'validation_technology_characteristics': {'method': 'lipid nanoparticles containing sgRNA', 'selectivity': 'Cas9 expression in ECs', 'outcome': 'EC-specific knockout mice', 'time_efficiency': 'days', 'cost_efficiency': '300€/mouse', 'scale': 'unprecedented'}}, 'goals': {'target_validation_number': 50, 'unknown_target_identification_number': 5, 'patent_aspiration': True}, 'tool_potential': {'SCMYSTERYDENTIFIER_generic_use': True, 'REVOLT_impact': 'accelerate genetic research in vascular biology', 'research_community_beneficiaries': ['academia', 'pharma']}, 'descriptions': ['Demystifying the mystery genome offers formidable opportunities for knowledge gain and therapy development.']}}\n\n**Description:**\n\n{'proposal_name': 'Endothelial immunosuppressive mystery genes for alternative immunotherapy: artificial intelligence-driven target discovery and lipid nanoparticle/RNA-based target validation', 'proposal_details': {'descriptions': ['This proposal aims to gain new insights into an endothelial cell subtype with immunomodulatory gene signatures for alternative immunotherapy development by silencing immunosuppressive genes.'], 'previous_grant_comparison': {'topic_difference': True, 'ambition_difference': True, 'societal_impact_focus': True}, 'research_areas': ['Endothelial cell immunomodulatory gene signatures', 'Alternative immunotherapy development'], 'technology': [{'name': 'SCMYSTERYDENTIFIER', 'type': 'AI-based tool', 'purpose': \"Predict new immunosuppressive functions for endothelial 'mystery' genes\"}, {'name': 'REVOLT', 'type': 'Technology', 'description': 'Injecting EC-selective lipid nanoparticles containing sgRNA in mice expressing Cas9 selectively in ECs', 'outcome': 'Rapid and inexpensive generation of EC-specific knockout mice'}], 'goals': {'validate_targets': 50, 'identify_and_patent_targets': 5}, 'cost_per_mouse': 300, 'currency': 'EUR', 'uncharacterized_genes_percentage': 30, 'potential_impacts': ['Knowledge gain', 'Therapy development', 'Pace of genetic research in vascular biology', 'Academic and pharmaceutical research']}}\n\n**Description:**\n\n{'proposal_name': 'Endothelial immunosuppressive mystery genes for alternative immunotherapy: artificial intelligence-driven target discovery and lipid nanoparticle/RNA-based target validation', 'proposal_details': {'previous_grants_comparison': {'topic_difference': True, 'ambition_difference': True, 'societal_impact_focus': True}, 'research_focus': {'cell_subtype': 'endothelial cell (EC)', 'cell_subtype_nickname': 'IMECs', 'gene_signatures': 'immunomodulatory', 'relevance': 'alternative immunotherapy development'}, 'therapeutic_strategy': {'gene_silencing': True, 'aim': 'improve anti-cancer immunotherapy efficacy', 'resistance_overcome': True, 'tumor_contribution': 'immunosuppressive tumor endothelium'}, 'target_discovery': {'unknown_targets': True, 'mystery_genes_percentage': 30}, 'tools_developed': {'AI_tool': {'name': 'SCMYSTERYDENTIFIER', 'purpose': 'predict immunosuppressive functions for endothelial mystery genes'}, 'validation_technology': {'name': 'REVOLT', 'method': 'EC-selective lipid nanoparticles with sgRNA', 'cas9_expression': 'mice with selective EC expression', 'knockout_mouse_generation_cost': 300, 'knockout_mouse_generation_time': 'days', 'scale': 'unprecedented'}}, 'goals': {'validate_targets': 50, 'identify_and_patent_targets': 5, 'target_nature': 'previously unknown for IMEC-based immunotherapy'}, 'potential_impact': {'knowledge_gain': True, 'therapy_development': True, 'research_tool_applicability': {'SCMYSTERYDENTIFIER_generic_use': True, 'REVOLT_impact': 'revolutionize genetic research pace in vascular biology'}, 'community_benefit': {'academia': True, 'pharma': True}}, 'descriptions': ['Demystifying the mystery genome offers formidable opportunities for knowledge gain and therapy development.']}}"
}